Document Detail


Outcome of intermittent tachyarrhythmias in the fetus.
MedLine Citation:
PMID:  9049114     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Persistent fetal tachycardias are known to have an adverse effect on fetal outcome. The outcomes of intermittent fetal tachyarrhythmias over a 12-year period at a tertiary fetal cardiology center were studied. Main outcome criteria included control of arrhythmia and death during the prenatal or postnatal period. A total of 28 fetuses had an intermittent tachyarrhythmia: 4 had intermittent atrial flutter and 24 had supraventricular tachycardia. At the time of presentation 14 fetuses were hydropic, and in 5 of the 14 an arrhythmia had not been noted prior to referral. Of the 28 fetuses, 23 were treated by drug administration to the mother. Control of arrhythmia was achieved in 10 of 11 (91%) nonhydropic fetuses and 8 of 12 (67%) hydropic fetuses, with resolution of hydrops in four cases. In the overall group there was one intrauterine death, two neonatal deaths, and one infant death, all of which occurred in the hydropic group. The arrhythmia recurred postnatally in 11 of 23 (48%) fetuses. We conclude that intermittent tachyarrhythmias may have a deleterious effect on the fetus with a significant risk of death pre- or postnatally. The fetus with nonimmune hydrops should be evaluated for a cardiac cause. Maternal antiarrhythmic therapy is indicated for intermittent fetal tachyarrhythmias. There is a high risk of recurrence of the arrhythmia during infancy, particularly if hydrops was documented during the prenatal period or if Wolff-Parkinson-White syndrome is diagnosed. Fetal echocardiography is a useful tool for diagnosis and for monitoring the progress of the fetus.
Authors:
J M Simpson; A Milburn; R W Yates; D J Maxwell; G K Sharland
Related Documents :
9258144 - Partial bladder outlet obstruction in the fetal rabbit.
7474054 - Pilot screening for fetal malformations: possibilities and limits of transvaginal sonog...
12811794 - Enlarged fetal bladder: differential diagnosis and outcomes.
11857624 - Usefulness of automated chromatography for rapid fetal blood analysis for second trimes...
15707714 - Prematurity and fetal growth restriction.
2026454 - The partially purified pre-implantation suppressor factor may be one of several factors...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pediatric cardiology     Volume:  18     ISSN:  0172-0643     ISO Abbreviation:  Pediatr Cardiol     Publication Date:    1997 Mar-Apr
Date Detail:
Created Date:  1997-03-28     Completed Date:  1997-03-28     Revised Date:  2008-02-20    
Medline Journal Info:
Nlm Unique ID:  8003849     Medline TA:  Pediatr Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  78-82     Citation Subset:  IM    
Affiliation:
Department of Fetal Cardiology, Guy's Hospital, London SE1 9RT, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Arrhythmia Agents / therapeutic use
Fetal Death / etiology
Fetal Diseases* / drug therapy
Gestational Age
Humans
Hydrops Fetalis / complications
Infant, Newborn
Recurrence
Retrospective Studies
Tachycardia* / complications,  drug therapy
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Presteady-state currents of the rabbit Na+/glucose cotransporter (SGLT1).
Next Document:  High prevalence of interatrial communications during the first three months of life.